Myelodysplastic syndromes (MDS) are a heterogeneous group of disorders clinically characterised by peripheral cytopenia, followed by a progressive impairment of myelodysplastic stem cells. The natural history of MDS, ranging from indolent conditions spanning years to forms rapidly progressing to leukaemia, are reviewed by Dr Nabil Aly as are methods of diagnosis and available therapies.